Skip to main content
Top
Published in: Critical Care 1/2004

01-02-2004 | Poster presentation

Benzisothiazole derivative inhibits toll-like receptor 4 signal transduction and prevents mice from the lethal shock

Authors: Y Hosaka, Y Shimizu, M Nakamura, Y Sato, Y Miyazaki, T Sato, M Mizuno, Y Kato, S Furusako

Published in: Critical Care | Special Issue 1/2004

Login to get access

Excerpt

Sepsis is a syndrome, a consequence of an overwhelming systemic response to infection. It rapidly leads to organ dysfunction, which accompanies systemic inflammation and hematological abnormalities. In Gram-negative bacteria, lipopolysaccharide (LPS) has a dominant role for the activation of various cells, which secrete several proinflammatory cytokines including TNF-α. These cytokines are also important in inducing a procoagulant effect in sepsis. On the other hand, toll-like receptor 4 (TLR4) is responsible for the LPS signaling and causes the activation of NF-κB. It is clear that an inappropriate TLR response to bacterial infection could have critical consequences. Therefore, TLR4 signal inhibitor is attractive as a therapeutic medication for sepsis. …
Metadata
Title
Benzisothiazole derivative inhibits toll-like receptor 4 signal transduction and prevents mice from the lethal shock
Authors
Y Hosaka
Y Shimizu
M Nakamura
Y Sato
Y Miyazaki
T Sato
M Mizuno
Y Kato
S Furusako
Publication date
01-02-2004
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2004
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2669

Other articles of this Special Issue 1/2004

Critical Care 1/2004 Go to the issue